vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $40.3M, roughly 1.4× Cambium Networks Corp). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -23.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-167.0M).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
CMBM vs PHAT — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $57.6M |
| Net Profit | $-7.2M | — |
| Gross Margin | 36.6% | 86.7% |
| Operating Margin | -28.4% | — |
| Net Margin | -17.9% | — |
| Revenue YoY | -23.2% | 94.1% |
| Net Profit YoY | 71.0% | 71.6% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.6M | ||
| Q3 25 | — | $49.5M | ||
| Q2 25 | — | $39.5M | ||
| Q1 25 | — | $28.5M | ||
| Q4 24 | $40.3M | $29.7M | ||
| Q3 24 | $44.7M | $16.4M | ||
| Q2 24 | $45.2M | $7.3M | ||
| Q1 24 | $47.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-30.0M | ||
| Q2 25 | — | $-75.8M | ||
| Q1 25 | — | $-94.3M | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-34.5M | $-85.6M | ||
| Q2 24 | $-14.2M | $-91.4M | ||
| Q1 24 | $-18.4M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | 36.6% | 87.1% | ||
| Q3 24 | 43.6% | 85.6% | ||
| Q2 24 | 32.5% | 81.2% | ||
| Q1 24 | 29.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -30.8% | ||
| Q2 25 | — | -151.7% | ||
| Q1 25 | — | -276.5% | ||
| Q4 24 | -28.4% | — | ||
| Q3 24 | -69.6% | -433.0% | ||
| Q2 24 | -27.2% | -1055.4% | ||
| Q1 24 | -33.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -60.5% | ||
| Q2 25 | — | -191.9% | ||
| Q1 25 | — | -330.7% | ||
| Q4 24 | -17.9% | — | ||
| Q3 24 | -77.3% | -523.3% | ||
| Q2 24 | -31.5% | -1248.6% | ||
| Q1 24 | -39.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.41 | ||
| Q2 25 | — | $-1.05 | ||
| Q1 25 | — | $-1.31 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-1.22 | $-1.32 | ||
| Q2 24 | $-0.51 | $-1.56 | ||
| Q1 24 | $-0.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | $67.6M | $209.1M |
| Stockholders' EquityBook value | $-3.2M | $-438.2M |
| Total Assets | $173.7M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | $67.6M | $201.4M | ||
| Q3 24 | $67.6M | $175.7M | ||
| Q2 24 | $68.9M | $174.4M | ||
| Q1 24 | $63.8M | — |
| Q4 25 | — | $-438.2M | ||
| Q3 25 | — | $-422.5M | ||
| Q2 25 | — | $-405.8M | ||
| Q1 25 | — | $-338.4M | ||
| Q4 24 | $-3.2M | $-253.6M | ||
| Q3 24 | $1.9M | $-187.1M | ||
| Q2 24 | $34.1M | $-233.8M | ||
| Q1 24 | $45.0M | — |
| Q4 25 | — | $259.1M | ||
| Q3 25 | — | $240.3M | ||
| Q2 25 | — | $250.2M | ||
| Q1 25 | — | $294.2M | ||
| Q4 24 | $173.7M | $378.3M | ||
| Q3 24 | $194.3M | $387.0M | ||
| Q2 24 | $221.1M | $319.4M | ||
| Q1 24 | $219.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-166.8M |
| Free Cash FlowOCF − Capex | $-10.8M | $-167.0M |
| FCF MarginFCF / Revenue | -26.8% | -290.0% |
| Capex IntensityCapex / Revenue | 1.1% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-166.8M | ||
| Q3 25 | — | $-14.1M | ||
| Q2 25 | — | $-62.7M | ||
| Q1 25 | — | $-84.9M | ||
| Q4 24 | $-10.4M | $-266.8M | ||
| Q3 24 | $8.9M | $-63.6M | ||
| Q2 24 | $2.4M | $-70.7M | ||
| Q1 24 | $-15.9M | — |
| Q4 25 | — | $-167.0M | ||
| Q3 25 | — | $-14.1M | ||
| Q2 25 | — | $-62.8M | ||
| Q1 25 | — | $-84.9M | ||
| Q4 24 | $-10.8M | $-266.9M | ||
| Q3 24 | $6.8M | $-63.6M | ||
| Q2 24 | $87.0K | $-70.8M | ||
| Q1 24 | $-17.4M | — |
| Q4 25 | — | -290.0% | ||
| Q3 25 | — | -28.6% | ||
| Q2 25 | — | -159.0% | ||
| Q1 25 | — | -297.9% | ||
| Q4 24 | -26.8% | -899.8% | ||
| Q3 24 | 15.2% | -389.0% | ||
| Q2 24 | 0.2% | -966.2% | ||
| Q1 24 | -37.0% | — |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 1.1% | 0.5% | ||
| Q3 24 | 4.8% | 0.3% | ||
| Q2 24 | 5.1% | 0.6% | ||
| Q1 24 | 3.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
PHAT
Segment breakdown not available.
